Patents Assigned to Cedars-Sinsai Medical Center
  • Use of GLP-1 receptor agonists for the treatment of short bowel syndrome
    Patent number: 8236760
    Abstract: The present invention describes the methods of using incretin mimetics such as GLP-1 receptor agonists, particularly exenatide, to treat short bowel syndrome and spastic or hyperactive esophageal motor disorders.
    Type: Grant
    Filed: April 24, 2008
    Date of Patent: August 7, 2012
    Assignee: Cedars-Sinsai Medical Center
    Inventors: Mark Pimentel, Edy E. Soffer, Jeffrey Conklin